Compare small molecule CDMOs for API synthesis, drug product formulation, and finished dosage manufacturing. Filter by chemistry capabilities, scale, and regulatory approvals.
406 companies listed
Small molecule manufacturing covers two distinct stages: active pharmaceutical ingredient (API) synthesis and drug product (DP) formulation. API work involves multi-step chemical synthesis, from kilo-lab through pilot-plant to commercial scale. Drug product work transforms the API into tablets, capsules, injectables, or other dosage forms.
Process chemistry is where projects succeed or fail. Look for CDMOs with strong route scouting and process optimization capabilities. A good CDMO can improve yields by 20-40% during scale-up, saving months of development time. Crystallization expertise is particularly critical for controlling polymorphic form and particle size distribution.
How does your CDMO handle potent compounds? Many oncology and hormonal APIs require OEB4 or OEB5 containment. Not every small molecule CDMO has the engineering controls for sub-microgram exposure limits. Verify containment capabilities early -- retrofitting is expensive and slow.
India
RNP Pharmachem is an Indian pharmaceutical company providing CDMO/CMO services and site transfer project activities. The company operates a Singapore EU-GMP approved manufacturing facility and has 51-200 employees. Limited information is available about the company's specific capabilities and therapeutic focus beyond its general CDMO/CMO service offering.
India
Elysium Pharmaceuticals Ltd. is an Indian pharmaceutical company based in Vadodara, Gujarat, with FDA-registered manufacturing facilities (1 FEI, 3 inspections including 1 NAI and 2 VAI). Limited public information is available due to website being down, but FDA registration and LinkedIn profiles confirm pharmaceutical manufacturing operations. Evidence of contract manufacturing is limited.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
